Matches in Wikidata for { <http://www.wikidata.org/entity/Q37840389> ?p ?o ?g. }
- Q37840389 description "2011 nî lūn-bûn" @default.
- Q37840389 description "2011年の論文" @default.
- Q37840389 description "2011年学术文章" @default.
- Q37840389 description "2011年学术文章" @default.
- Q37840389 description "2011年学术文章" @default.
- Q37840389 description "2011年学术文章" @default.
- Q37840389 description "2011年学术文章" @default.
- Q37840389 description "2011年學術文章" @default.
- Q37840389 description "2011年學術文章" @default.
- Q37840389 description "2011年學術文章" @default.
- Q37840389 description "2011年學術文章" @default.
- Q37840389 description "2011年學術文章" @default.
- Q37840389 description "2011年學術文章" @default.
- Q37840389 description "2011년 논문" @default.
- Q37840389 description "article científic" @default.
- Q37840389 description "article scientific" @default.
- Q37840389 description "article scientifique publié en 2011" @default.
- Q37840389 description "articol științific" @default.
- Q37840389 description "articolo scientifico" @default.
- Q37840389 description "artigo científico (publicado na 2011)" @default.
- Q37840389 description "artigo científico (publicado na 2011)" @default.
- Q37840389 description "artigo científico" @default.
- Q37840389 description "artikull shkencor" @default.
- Q37840389 description "artikulong pang-agham" @default.
- Q37840389 description "artykuł naukowy" @default.
- Q37840389 description "artículo científico publicado en 2011" @default.
- Q37840389 description "artículu científicu espublizáu en 2011" @default.
- Q37840389 description "bilimsel makale" @default.
- Q37840389 description "bài báo khoa học" @default.
- Q37840389 description "mokslinis straipsnis" @default.
- Q37840389 description "naučni članak" @default.
- Q37840389 description "scienca artikolo" @default.
- Q37840389 description "scientific article published on 18 February 2011" @default.
- Q37840389 description "teaduslik artikkel" @default.
- Q37840389 description "tieteellinen artikkeli" @default.
- Q37840389 description "tudományos cikk" @default.
- Q37840389 description "vedecký článok" @default.
- Q37840389 description "vetenskaplig artikel" @default.
- Q37840389 description "videnskabelig artikel (udgivet 2011)" @default.
- Q37840389 description "vitenskapelig artikkel" @default.
- Q37840389 description "vitskapeleg artikkel" @default.
- Q37840389 description "vědecký článek" @default.
- Q37840389 description "wetenschappelijk artikel" @default.
- Q37840389 description "wissenschaftlicher Artikel" @default.
- Q37840389 description "επιστημονικό άρθρο" @default.
- Q37840389 description "мақолаи илмӣ" @default.
- Q37840389 description "мақолаи илмӣ" @default.
- Q37840389 description "наукова стаття, опублікована в лютому 2011" @default.
- Q37840389 description "научна статия" @default.
- Q37840389 description "научная статья" @default.
- Q37840389 description "научни чланак" @default.
- Q37840389 description "научни чланак" @default.
- Q37840389 description "գիտական հոդված" @default.
- Q37840389 description "מאמר מדעי" @default.
- Q37840389 description "سائنسی مضمون" @default.
- Q37840389 description "مقالة علمية نشرت في 18 فبراير 2011" @default.
- Q37840389 description "مقالهٔ علمی" @default.
- Q37840389 description "২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q37840389 description "บทความทางวิทยาศาสตร์" @default.
- Q37840389 description "სამეცნიერო სტატია" @default.
- Q37840389 name "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer" @default.
- Q37840389 name "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer" @default.
- Q37840389 name "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer." @default.
- Q37840389 type Item @default.
- Q37840389 label "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer" @default.
- Q37840389 label "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer" @default.
- Q37840389 label "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer." @default.
- Q37840389 prefLabel "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer" @default.
- Q37840389 prefLabel "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer" @default.
- Q37840389 prefLabel "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer." @default.
- Q37840389 P1433 Q37840389-3BC05E79-0947-4170-BD6A-BD772FABA3ED @default.
- Q37840389 P1476 Q37840389-6FB9003B-1D6E-4721-95C4-C9BAD1867440 @default.
- Q37840389 P2093 Q37840389-3067D9A2-7B18-4504-8F5E-0518D092BD05 @default.
- Q37840389 P2093 Q37840389-76D1A570-3804-4469-9BB9-2F204A775465 @default.
- Q37840389 P2093 Q37840389-93D6FCD8-E6DA-4655-9C9A-61BDEE3246B7 @default.
- Q37840389 P2093 Q37840389-9560F5BB-58B7-4FE8-8321-D1E002198FDA @default.
- Q37840389 P2093 Q37840389-C412861F-BA3C-4A6F-99E2-2618BE6EAE3C @default.
- Q37840389 P2093 Q37840389-C4E4B4A0-3FD7-43A6-A011-5A579EE0B07E @default.
- Q37840389 P2093 Q37840389-D40750CA-4EC8-4FB1-A080-A4F7B0E5C7C1 @default.
- Q37840389 P2860 Q37840389-067949D1-4888-47F8-8D7B-D007A98C36BC @default.
- Q37840389 P2860 Q37840389-10C0CF42-4885-4A47-911E-E3F08B1BA6CD @default.
- Q37840389 P2860 Q37840389-1B7E6E58-875B-420E-8825-9A4B57FA7F40 @default.
- Q37840389 P2860 Q37840389-23861666-61FB-4F1A-973F-54EB874EBBBD @default.
- Q37840389 P2860 Q37840389-687CE980-6FCF-4AEC-9895-DDEC8CC4BB79 @default.
- Q37840389 P2860 Q37840389-6A3DDA56-9F39-4A51-80A1-EE36DD43E816 @default.
- Q37840389 P2860 Q37840389-6AF0F89C-B62F-4CC2-A16A-E0D1C6167D1B @default.
- Q37840389 P2860 Q37840389-78B80E00-BDB2-41FC-8102-CDE0C823BA3F @default.
- Q37840389 P2860 Q37840389-842F474E-E722-41F8-8D3D-CC76F59AA8E3 @default.
- Q37840389 P2860 Q37840389-9407F43E-60A3-450A-B1BC-656D599B9DE3 @default.
- Q37840389 P2860 Q37840389-B93971F0-C773-40E5-8877-4440C6FDDC5B @default.
- Q37840389 P2860 Q37840389-C25F08BF-31A2-4AD9-823F-341DF54CEB1E @default.
- Q37840389 P2860 Q37840389-C46B7075-4032-415C-A545-4D12FF690EB6 @default.
- Q37840389 P2860 Q37840389-E6431567-AF69-41E1-95C6-B0FF65A64418 @default.
- Q37840389 P2860 Q37840389-E9596345-8268-4BDA-A4DF-9980329E2D05 @default.
- Q37840389 P2860 Q37840389-F98FA041-82E6-4C08-B299-7D3F1F75BF84 @default.
- Q37840389 P304 Q37840389-3A52E38A-42ED-4754-ADAC-E8B579D58222 @default.
- Q37840389 P31 Q37840389-5436BBA2-2AFC-465A-978B-A0D1204AB14C @default.
- Q37840389 P356 Q37840389-199FF40C-99A8-43F2-AA65-D75A02E24930 @default.
- Q37840389 P407 Q37840389-E9FAEED9-AC01-4D22-8E31-9C0B5AA17B75 @default.
- Q37840389 P433 Q37840389-AB8777EC-8003-47BD-BF6C-C7CC8CEC8A72 @default.